Technology

MBK Rental Living's new Las Brisas community offers resort-style amenities, but its launch highlights the complex housing pressures on California's Central Coast.

The digital lender's record revenue and new blockchain platform aim to unlock trillions in illiquid home equity, charting a bold path to profitability.

The robotics firm completed crucial benchtop tests for its novel single-port system, a major step toward clinical use and challenging market leaders.

NASDAQ-listed Bio Green Med Solution abandons its biopharma roots for fire safety, slashing losses but facing new questions about its long-term survival.

As The Hanover prepares its Q1 2026 report, investors watch to see if it can sustain momentum amid inflation, high rates, and catastrophe risks.

With a new manufacturing chief from Amazon Robotics, the Houston startup is scaling production of humanoids to tackle critical labor shortages in heavy industry.

As Industry 4.0 merges factories and data centers, the gap between IT and OT monitoring has become a dangerous blind spot for security and operations.

The direct-to-consumer brand hit a $100M run rate with natural supplements, attracting major investors. But do the scientific claims hold up?

Coro's new AI integration lets users manage security via ChatGPT, but this leap in convenience comes with a new frontier of potential security risks.

How a mortgage giant traded manual spreadsheets for custom AI, scaling loan volume 10x and saving millions, rewriting the playbook for growth.

HistoSonics begins a landmark trial for a non-invasive BPH therapy that uses focused ultrasound to mechanically destroy tissue without incisions or heat.

A new partnership between Takara Bio and Hamilton promises to revolutionize RNA-seq, making high-throughput genomic analysis faster and more reliable.

An ETF offers retail investors a ticket to SpaceX's massive IPO, but a bitter public dispute with critics raises questions about transparency and risk.

Neumora reveals promising data for Alzheimer's and schizophrenia drugs, but a delay in its obesity program highlights the high-stakes world of biotech.

Analyses reveal the EPA allows pesticides with high cancer risks on the market without warning labels, raising major public health and legal questions.

A new report reveals a major shift in cybercrime, with attackers now preferring stolen credentials over hacking to breach corporate networks.

Top execs from Hyundai, dealer associations, and policy groups will debate the future of EVs, trade, and affordability at a critical new NYIAS panel.

In just six months, OpenArc surpassed $10 billion in assets, validating a new model that integrates corporate benefits with personal wealth advice.

Canada's $4T investment sector warns new investor protection rules are too costly, sparking a debate on market safety versus industry competitiveness.

As co-founder Jürgen Bickel steps down, 14-year veteran David Männer takes the helm to navigate Storz & Bickel's future and drive Canopy's U.S. plans.